Send us a text

In this episode of Endurance Dad, we’re diving deep into the truth about GLP-1 medications like Ozempic, Wegovy, Mounjaro, and the newly approved Zepbound. These drugs have taken the weight loss world by storm, but are they really the solution for everyone?

We’ll break down:
✅ How these medications work for weight loss
✅ The benefits and risks of using them
✅ Who should (and shouldn’t) consider taking them
✅ Whether you can lose weight naturally without them
✅ The future of GLP-1 drugs and where things are headed

If you're wondering whether these medications are right for you—or just want to understand the hype—this episode is packed with research-backed insights!

💬 What do you think about GLP-1 drugs? Have you tried them? Would you consider it? Let’s continue the conversation!

⭐ If you enjoyed this episode, please leave us a rating & review on [Spotify/Apple Podcasts]!

🎧 Next Episode: Fad-Diets vs Science: How to lose 1-2 lbs per week consistently

🔥 Subscribe for more in-depth health and endurance training discussions!

Resources & References

1. FDA Approval of Zepbound for Weight Loss – FDA.gov
2. Wilding, J.P.H., et al. (2021). "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine.
3. Jastreboff, A.M., et al. (2022). "Tirzepatide for Obesity Treatment." The Lancet Diabetes & Endocrinology.
4. Rubino, D., et al. (2023). "GLP-1 and GIP Mechanisms in Weight Loss." Diabetes, Obesity and Metabolism.

⬆️ Send us a text at the link above with questions for the show, show ideas, comments, or if you want to be a guest on the show.

🌎 Check out our website

http://www.endurancedad.fm

🔗 Follow us on Instagram

https://instagram.com/ultraorthodoc

🎙️ Love the podcast? Leave a review on Apple Podcasts & Spotify!